Vaginal oestrogen for overactive bladder in post-menopausal women.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  British Journal of Nursing

• Publication date

  2015-06-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.12968/bjon.2015.24.11.582PMID 26067792
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Local oestrogen for vaginal atrophy in postmenopausal women.

  2016cited by this paper
• Global prevalence and economic burden of urgency urinary incontinence: a systematic review.

  2014cited by this paper
• Economics of Overactive Bladder

  2014cited by this paper
• Triple therapy with Lactobacilli acidophili, estriol plus pelvic floor rehabilitation for symptoms of urogenital aging in postmenopausal women

  2014cited by this paper
• The effect of hormones on the lower urinary tract

  2013cited by this paper
• Pathophysiology of overactive bladder

  2012cited by this paper
• The role of local vaginal estrogen treatment in urogenital atrophy

  2012cited by this paper
• Impact of overactive bladder on work productivity.

  2012cited by this paper
• Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS.

  2012cited by this paper
• Oestrogen therapy for urinary incontinence in post-menopausal women.

  2012cited by this paper
• An overview of chronic vaginal atrophy and options for symptom management.

  2012cited by this paper
• An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction

  2010cited by this paper
• Recognizing and Treating Urogenital Atrophy in Postmenopausal Women

  2010cited by this paper
• Efficacy and tolerability of local estrogen therapy for urogenital atrophy

  2010cited by this paper
• The overactive bladder

  2010cited by this paper
• Recommendations for the management of postmenopausal vaginal atrophy

  2010cited by this paper
• Impact of Overactive Bladder Symptoms on Sexuality in Both Sexes

  2010cited by this paper
• Clinically Oriented Anatomy, 6th edn.

  2009cited by this paper
• Managing urogenital atrophy.

  2009cited by this paper
• Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview

  2009cited by this paper
• Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women

  2008cited by this paper
• Hormone replacement therapy: risks and benefits

  2008cited by this paper
• Effective Treatment of Vaginal Atrophy With an Ultra–Low-Dose Estradiol Vaginal Tablet

  2008cited by this paper
• P45.02: Ultrasound examination of the female utrethra after short‐term intravaginal estrogen treatment

  2008cited by this paper
• Local oestrogen for vaginal atrophy in postmenopausal women.

  2006cited by this paper
• Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

  2006cited by this paper
• A study on urogenital complaints of postmenopausal women aged 50 and over

  2005cited by this paper
• SOGC clinical practice guidelines. The detection and management of vaginal atrophy. Number 145, May 2004.

  2005cited by this paper
• Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women

  2004cited by this paper
• Self-reported urogenital symptoms in postmenopausal women: Women's Health Initiative.

  2004cited by this paper
• The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.

  2003cited by this paper
• Promoting continence : a clinical and research resource

  2003cited by this paper
• Local estrogen treatment in patients with urogenital symptoms

  2003cited by this paper
• A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer

  2003cited by this paper
• The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence Society

  2002cited by this paper
• Factors associated with age at natural menopause in a multiethnic sample of midlife women.

  2001cited by this paper
• META‐ANALYSIS OF ESTROGEN THERAPY IN THE MANAGEMENT OF UROGENITAL ATROPHY IN POSTMENOPAUSAL WOMEN: SECOND REPORT OF THE HORMONES AND UROGENITAL THERAPY COMMITTEE

  1998cited by this paper
• Low-dose 17 beta-estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled study.

  1992cited by this paper
• Clinically Oriented Anatomy

  1985cited by this paper
• Prevalence of Genitourinary Symptoms in the Late Menopause

  1984cited by this paper
• Estrogen receptors in the human female lower urinary tract

  1981cited by this paper
• Estrogen receptors in the human female lower uninary tract.

  1981cited by this paper

• Effect of Oral estrogen on overactive bladder in women: A research based on NHANES and network pharmacology.

  2025cites this paper
• Overactive bladder: not just a normal part of getting older.

  2022cites this paper
• Quality of Life before and after the Use of Vaginal Estriol in Postmenopausal Women with Lower Urinary Tract Symptoms

  2020cites this paper
• Pelvic Floor, Urinary Problems and the Menopause

  2020cites this paper
• Selecting appropriate absorbent products to treat urinary incontinence.

  2015cites this paper
• Selecting appropriate absorbent products to treat urinary incontinence

  2015cites this paper